Raymond James & Associates’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$465K Buy
+27,630
New +$465K ﹤0.01% 3142